Your browser doesn't support javascript.
loading
Letter comments on: Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma.
Rebuzzi, Sara Elena; Fornarini, Giuseppe; Banna, Giuseppe Luigi; Rescigno, Pasquale; Buti, Sebastiano.
Affiliation
  • Rebuzzi SE; Medical Oncology Unit, Ospedale San Paolo, Savona, Italy; Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genova, Genova, Italy. Electronic address: saraelena89@hotmail.it.
  • Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Banna GL; Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth PO6 3LY, United Kingdom; Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth PO1 2UP, United Kingdom.
  • Rescigno P; Translationsal and Clinical Research Institute, Centre for Cancer, Newcastle University, Newcastle Upon Tyne, United Kingdom; Candiolo Cancer Institute, FPO-IRCCS, Turin, Candiolo, Italy.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy.
Eur J Cancer ; 205: 114097, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38735162
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms / Lung Neoplasms Limits: Humans Language: En Journal: Eur J Cancer Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Renal Cell / Kidney Neoplasms / Lung Neoplasms Limits: Humans Language: En Journal: Eur J Cancer Year: 2024 Document type: Article